Market Cap

Neovasc Inc. Market Capitalization:

C$111.8 Million

CAD as of April 1, 2023

US$84.4 Million

business Neovasc Inc. Company Profile

Neovasc Inc. Main Stock Listing

TSX: NVCN

Market Capitalization History of Neovasc Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $216.15 B
Boston Scientific Corporation $140.40 B
Stryker $133.15 B
Medtronic $123.20 B
Edwards Lifesciences Corporation $50.10 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Neovasc Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 C$101.9 M 164.43%
Jan. 1, 2022 C$38.6 M -62.16%
Jan. 1, 2021 C$101.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Neovasc Inc. Categories

Canada languages Healthcare languages Medical Devices
Canada Healthcare Canada Medical Devices

Stocks & Indices

Neovasc Inc. has the following listings and related stock indices.


Stock: TSX: NVCN

Stock: NASDAQ: NVCN

Stock: FSX: G5Z3

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.